Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
STAP2 encodes the substrate of breast tumor kinase, an Src-type non-receptor tyrosine kinase. De plus, nous expédions Signal Transducing Adaptor Family Member 2 Anticorps (97) et Signal Transducing Adaptor Family Member 2 Protéines (4) et beaucoup plus de produits pour cette protéine.
High STAP2 expression is associated with prostate cancer.
The Pyk2 (Montrer PTK2B Kits ELISA)/STAP-2 interaction is a novel mechanism to regulate SDF-1alpha-dependent T-cell chemotaxis.
STAP2 is upregulated in uterosacral ligaments in pelvic organ prolapse
Our results demonstrate a critical contribution of STAP-2 in BCR-ABL (Montrer ABL1 Kits ELISA) activity.
STAP-2 is a novel participant in the regulation of T cell apoptosis after stimulation
Interactions of STAP-2 with Brk (Montrer PTK6 Kits ELISA) and STAT3 (Montrer STAT3 Kits ELISA) participate in cell growth of human breast cancer cells.
STAP-2 expression in Jurkat T cells affects migration following stromal cell-derived factor-1alpha (SDF-1alpha) treatment; STAP-2 association with Vav1, the guanine-nucleotide exchanging factor for Rac1, enhances downstream Vav1/Rac1 signaling.
These data indicate that STAP-2/BKS negatively controls the FcepsilonRI (Montrer FCER1G Kits ELISA)-mediated calcium mobilization and degranulation by direct modulation of tyrosine phosphorylation of PLC (Montrer HSPG2 Kits ELISA)-gamma.
STAP-2/BKS is a modulator of STAT5 (Montrer STAT5A Kits ELISA)-mediated signaling
STAP-2 associates with FAK (Montrer PTK2 Kits ELISA) and enhances its degradation, proteasome inhibitors block FAK (Montrer PTK2 Kits ELISA) degradation, and STAP-2 recruits an endogenous E3 ubiquitin ligase, Cbl (Montrer CBL Kits ELISA), to FAK (Montrer PTK2 Kits ELISA).
results demonstrate a contribution of CCR7 (Montrer CCR7 Kits ELISA) to STAP-2-dependent enhancement of BCR-ABL (Montrer ABL1 Kits ELISA)-mediated cell growth in Ba/F3 cells
signal transducing adaptor protein 2 (STAP-2) is involved in cell migration, proliferation, and melanogenesis as well as chemokine receptor expression and tumorigenesis in B16F10 melanoma cells
STAP-2 has a potential to regulate plural molecular events during pathological inflammatory responses.
Signal-transducing adaptor protein-2 controls the IgE-mediated, mast cell-mediated anaphylactic responses.
STAP-2 directly binds to c-Fms (Montrer CSF1R Kits ELISA) and interferes with the PI3K signaling, which leads to macrophage motility, in Raw 264.7 cells
These results suggest that STAP-2 acts as an endogenous negative regulator of Epstein-Barr virus LMP1 (Montrer PDLIM7 Kits ELISA)-mediated signaling through TRAF3 (Montrer TRAF3 Kits ELISA) and TRADD (Montrer TRADD Kits ELISA).
This gene encodes the substrate of breast tumor kinase, an Src-type non-receptor tyrosine kinase. The encoded protein possesses domains and several tyrosine phosphorylation sites characteristic of adaptor proteins that mediate the interactions linking proteins involved in signal transduction pathways. Alternative splicing results in multiple transcript variants.
signal-transducing adaptor protein 2
, BRK substrate
, breast tumor kinase substrate
, brk kinase substrate
, signal-transducing adaptor protein-2